These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9592620)

  • 1. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.
    Le Couteur DG; McLean AJ
    Clin Pharmacokinet; 1998 May; 34(5):359-73. PubMed ID: 9592620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics in patients with liver disease.
    McLean AJ; Morgan DJ
    Clin Pharmacokinet; 1991 Jul; 21(1):42-69. PubMed ID: 1914341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
    Le Couteur DG; Fraser R; Hilmer S; Rivory LP; McLean AJ
    Clin Pharmacokinet; 2005; 44(2):187-200. PubMed ID: 15656697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging biology and geriatric clinical pharmacology.
    McLean AJ; Le Couteur DG
    Pharmacol Rev; 2004 Jun; 56(2):163-84. PubMed ID: 15169926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver function and phase I drug metabolism in the elderly: a paradox.
    Schmucker DL
    Drugs Aging; 2001; 18(11):837-51. PubMed ID: 11772124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs and the liver. Part III: Ageing of the liver and the metabolism of drugs.
    Woodhouse K
    Biopharm Drug Dispos; 1992 Jul; 13(5):311-20. PubMed ID: 1498264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J; Bergmann JF; Caulin C; Segrestaa JM
    Therapie; 1990; 45(2):91-7. PubMed ID: 2191470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation study on the effect of a uniform diffusional barrier across hepatocytes on drug metabolism by evenly or unevenly distributed uni-enzyme in the liver.
    Sato H; Sugiyama Y; Miyauchi S; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1986 Jan; 75(1):3-8. PubMed ID: 3958902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
    Alcorn J; McNamara PJ
    Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy in the elderly.
    Turnheim K
    Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics in older persons.
    Cusack BJ
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):274-302. PubMed ID: 15903286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.